शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
SUNPHARMABSESun Pharmaceutical Industries Ltd· Pharmaceuticals & BiotechnologyHighNegative
Announced Thu, 10 Jul, 2025 · 16:39 IST

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 10, 2025 for Raksha Sudhir Valia

SUNPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.7%Reaction day
₹1663.20
prior close
₹1665.80
announcement price
After-mkt
timing
Nifty 100market · index membership as recorded later (tracked since Jun 2026)-0.8%+1.5% vs market
Pharmaceuticals peers, median of 151sector-0.2%+0.9% vs sector

On the reaction day the stock moved 1.5 pts more than Nifty 100 and 0.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.2
10m
+0.2
15m
+0.3
30m
+0.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.7-0.8+1.5-0.2+0.9
Next day
+1.1-1.0+2.1+0.6+0.5
2d
+4.0-0.5+4.4+1.5+2.5
3d
+2.5-0.4+2.8+2.1+0.4
4d
+2.4-0.8+3.1+2.7-0.3
5d
+1.9-1.3+3.2+2.1-0.3
1w
+1.2-1.0+2.2+0.8+0.4
15d
-2.0-3.2+1.1-2.3+0.3
1m
-3.1-3.1-0.0-4.3+1.2
2m
-3.3-1.3-2.0-2.3-1.0
3m
+0.2-0.4+0.6-5.5+5.7
UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 151Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Raksha Sudhir Valia, a Person Acting in Concert (PAC) with the promoter group of Sun Pharmaceutical Industries, has pledged 6,50,000 equity shares (about 0.027% of total share capital) on July 4, 2025. The pledge was created in favor of Citicorp Finance (India) Limited as security for a loan facility availed by a third party. After this pledge, her encumbered shares stand at 1,19,90,400 (0.499% of share capital), out of her total holding of 28,830,352 shares (1.20%). This is a routine disclosure under SEBI's takeover regulations to inform exchanges about the encumbrance.

Likely market impact

This is a routine regulatory disclosure and a small pledge creation relative to overall shareholding. It is not expected to have any meaningful impact on the stock price. Investors may note that the pledge is for a third-party loan, not the company's own borrowings.